Results 161 to 170 of about 19,061 (206)

Correction: Evaluation of the responsiveness of the Iranian health system to the needs of the elderly during the COVID-19 pandemic: a community-based study. [PDF]

BMC Health Serv Res
Niazie S, Heydari H, Hayati H, Dehghani A.   +3 more
europepmc   +1 more source

Cost-effectiveness analysis of belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma in the United States and China. [PDF]

Ther Adv Med Oncol
Ding B, Yao H, Tao T, Sun Y, Zhu Y, Zhu H, Wang J, Jing Z, Gao L, Lin Y, Li X.   +10 more
europepmc   +1 more source

The clinical importance of the cardiovascular-kidney-metabolic syndrome and related mortality. [PDF]

Front Clin Diabetes Healthc
Hoffmann K, Paczkowska A, Maggio V, Rizzo M.   +3 more
europepmc   +1 more source

Physician Perspectives on Pharmaceutical Promotion.

JAMA Health Forum
Mooney H, Austad K, Campbell EG, Avorn J, Lu Z, Kesselheim AS.   +5 more
europepmc   +1 more source

Correction: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications. [PDF]

Pharmacoeconomics
Campbell JA, Henson GJ, Ngwa VF, Ahmad H, Taylor BV, van der Mei I, MSBase Australian Researchers, Palmer AJ.   +7 more
europepmc   +1 more source

Translation and Cultural Adaptation of the Measure Yourself Concerns and Wellbeing (MYCaW) Questionnaire Into German: Protocol for the iSWOP Study.

JMIR Res Protoc
Thronicke A, Schille L, Adie K, Junghanss C, Oei SL, Johnson S, Roos J, Schad F.   +7 more
europepmc   +1 more source

Recent changes in discretionary denials of drug patent challenges. [PDF]

Health Aff Sch
Tu SS, Rai A, Kesselheim AS.
europepmc   +1 more source

Revenue Differences Between Top-Selling Small-Molecule Drugs and Biologics in Medicare.

JAMA Health Forum
Vogel M, Feldman WB, Cowan Z, Rome BN, Chandra A, Kesselheim AS, Wouters OJ.   +6 more
europepmc   +1 more source